Close

Analyst Ratings for GlaxoSmithKline (GSK) [Sells]

GSK Rating Summary

GSK Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GSK
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $46.00 (+7%) * Over Last 12-Mos
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/5/2022 BofA Securities Graham Perry New Coverage Underperform
(N/A)
36.00
(N/A)
35.35
(42.99)
21.61% Details
11/11/2022 UBS Michael Leuchten Downgrade Sell
(Neutral)
N/A
(N/A)
33.47
(42.99)
28.44% Details
Like GSK Ratings? Also take a look at PFE, BLU, SCYX, ARWR

GSK Ratings News